Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
4
×
clinical trials
life sciences
national blog main
national top stories
4
×
new york blog main
new york top stories
fda
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boston
drugs
akcea therapeutics
allergan
allopregnanolone
alnylam pharmaceuticals
andrew fire
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brexanolone
bristol-myers squibb
cancer
clinical data
companion diagnostic
craig mello
detroit blog main
detroit top stories
dna sequencing
entrectinib
express scripts
foundation medicine
genfit
gilead sciences
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
What
approved
4
×
drug
medicine
4
×
fda
new
oks
specifically
afternoon
alnylam
alnylam’s
brexanolone
cancer
data
deeper
depression
devastating
disease
disorder
dna
fast
fatty
fingerprint
genetic
gets
going
history
horizon
intercept
known
landmark
liver
making
marketed
matter
moms
nash
nd
nonalcoholic
ok
onpattro
Language
Current search:
approved
×
medicine
×
" boston blog main "
×
" national top stories "
×
" boston top stories "
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug